Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 23, 2026

Tenable, PagerDuty, and HubSpot Shares Are Falling, What You Need To Know

View original at finance.yahoo.com
Tenable, PagerDuty, and HubSpot Shares Are Falling, What You Need To Know Tenable, PagerDuty, and HubSpot Shares Are Falling, What You Need To Know What Happened?…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Market fear persists that AI agents will erode the subscription model underpinning traditional enterprise software economics.

    60% confidence
  • Software stocks may remain in the penalty box until companies can prove AI revenue scales faster than it erodes the legacy subscription base.

    60% confidence
  • The market is pricing AI cannibalization of legacy software as if it has already happened, but income statements may indicate otherwise.

    60% confidence
  • AI is compressing demand for traditional IT services, directly reducing billable hours at Accenture.

    60% confidence
  • Salesforce is a Buy on valuation.

    60% confidence
  • The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

    60% confidence
  • The sector-wide software selloff was indiscriminate, driven mechanically by the index weight of Alphabet and Microsoft.

    60% confidence
  • Salesforce is acquiring m3ter precisely to monetize AI agent actions rather than seats, positioning itself for a usage-based revenue transition.

    60% confidence
  • Adobe has not traded this cheaply on an earnings basis in over a decade.

    60% confidence
  • Salesforce is a Rule-of-40 company, retiring 10% of its shares through a $25 billion buyback and carries the largest AI revenue line in the CRM category.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Tenable, PagerDuty, and HubSpot Shares Are Falling, What You Need To Know — Source | Via News | ViaNews Market